OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Dublin, March 11, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/rhvbfw/metered_dose) has announced the addition of the "Metered Dose Inhalers to 2022" report to their offering.
This report examines the current and future metered dose inhalers market and the key topics all market participants should be aware of. Recent improvements in the control of the inspiry event have reduced the need for add-on devices designed to help regulate patient administration. Growth in upper airway therapeutics will help to push MDI unit demand to high single digits between now and the end of the decade.
Questions Answered:
- What inhalable drugs are supplied in MDIs, how are they marketed, what are the device specifics, and who markets them?
- What inhalable MDI products are in late stage development, who are the developers, and what indications are they targeting?
- What are the major factors driving metered dose inhaled drug/device demand?
- What is the size of the market today, who are the market share leaders, and what will the market share be in 2022?
- How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
- What are the essential design factors, material selection issues, technologies and market development issues MDI products?
- What are the significant economic, technology, and regulatory factors affecting the market for MDIs?
Report Structure:
1. Executive Summary
2. Inhaled Drug Delivery Market Dynamics
3. Devices and Formulations
4. MDI Technology Factors
5. MDI Performance Factors
6. MDI Product Assessments and Analysis
7. Therapeutic Market Analysis, Market Data and Forecasts
8. Market Factors
9. Company Profiles
For more information visit http://www.researchandmarkets.com/research/rhvbfw/metered_dose
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Inhalers and Nebulisers, Respiratory Devices
